For renal cancer VEGF, which is crucial in tumor angiogenesis and is often elevated in renal cell carcinoma (RCC), and CA 9 serve as prognostic markers and are used to predict responses, for example, to anti-angiogenic therapies [44,45]. The gene discussed is VEGFA; the disease is renal carcinoma.